Effect of autologous bone marrow derived mesenchymal stem cells in treatment of rheumatoid arthritis.

Introduction: Chronic inflammation causes articular bone and cartilage degeneration in people with rheumatoid arthritis (RA). Despite recent advancements in the management of RA, adverse side effects and ineffective treatments remain a problem. Effective treatment is usually hampered by financial issues.